medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-2-60-63medsovet-41Research ArticleИнфекции в акушерстве и гинекологииInfections in obstetrics and gynecologyКлиническая эффективность флуконазола в лечении вульвовагинального кандидозаThe clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasisСеровВ. Н.SerovV. N.noemail@neicon.ruБуралкинаН. А.BuralkinaN. A.noemail@neicon.ruБорисенкоМ. Ю.BorisenkoM. Y.noemail@neicon.ruМамедоваФ. Ш.MamedovaF. Sh.noemail@neicon.ruНаучный центр акушерства, гинекологии и перинатологии им. акад. В.И. КулаковаРоссияScientific center for obstetrics, gynecology and perinatology named after acad. V.I. KulakovRussian Federation201630122016026063Copyright © Серов В.Н., Буралкина Н.А., Борисенко М.Ю., Мамедова Ф.Ш., 20162016Серов В.Н., Буралкина Н.А., Борисенко М.Ю., Мамедова Ф.Ш.Serov V.N., Buralkina N.A., Borisenko M.Y., Mamedova F.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/41

В статье отражены основные проблемы диагностики и лечения пациенток с вульвовагинальным кандидозом (ВВК). Отмечено, что Candida albicans вызывает кандидоз в 75-80% случаев. Клиническими формами ВВК являются: кандидоносительство, острый ВВК, хронический (рецидивирующий) вульвовагинальный кандидоз (ХРВВК). Описаны основные диагностические подходы к лечению и предотвращению рецидивов заболевания. Авторы представили данные об эффективности антифугального препарата Дифлюкан в борьбе с ВВК.

The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases. Clinical forms of VVC include: Candida-carrying, acute VVC, chronic (recurrent) vulvovaginal candidiasis (CRVVC). The main diagnostic approaches to the treatment and prevention of recurrence of the disease are described. The authors presented data on the efficacy of the antifungal medication Diflucan in the fight against VVC.

вульвовагинальный кандидоздиагностикалечениеCandida albicansДифлюканvulvovaginal candidiasisdiagnosistreatmentDiflucanCandida albicansReferencesFoxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self- reported incidence and associated costs. Sex Transm Dis, 2000, 27: 230-235.Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self- reported incidence and associated costs. Sex Transm Dis, 2000, 27: 230-235.Ogouyemi-Hounto A, Adisso S, Djamal J, Sanni R, Amangbegnon R, Biokou-Bankole B, Kinde Gazard D,Massougbodji A. Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. J Mycol Med., 2014 Jun, 24(2): 100-5.Ogouyemi-Hounto A, Adisso S, Djamal J, Sanni R, Amangbegnon R, Biokou-Bankole B, Kinde Gazard D,Massougbodji A. Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. J Mycol Med., 2014 Jun, 24(2): 100-5.Uvarova EV. Vulvovaginal candidiasis in girls (guidelines for a practitioner). Antibiot Khimioter., 2007, 52(4-5): 49-55. [Article in Russian]Uvarova EV. Vulvovaginal candidiasis in girls (guidelines for a practitioner). Antibiot Khimioter., 2007, 52(4-5): 49-55. [Article in Russian]Hoffmann JN, You HM, Hedberg EC, Jordan JA, McClintock MK. Prevalence of bacterial vagi-nosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci SocSci., 2014, Nov, 69 Suppl 2: S205-14.Hoffmann JN, You HM, Hedberg EC, Jordan JA, McClintock MK. Prevalence of bacterial vagi-nosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci SocSci., 2014, Nov, 69 Suppl 2: S205-14.Hamad M, Kazandji N, Awadallah S, Allam H. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses., 2014 Mar, 57(3): 184-90.Hamad M, Kazandji N, Awadallah S, Allam H. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses., 2014 Mar, 57(3): 184-90.Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии под редакцией акад. В.И. Кулакова, проф. В.Н. Прилепской, В.Е. Радзинского. М.: «ГЭОТАР-Медиа», 2006. с. 1029.Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии под редакцией акад. В.И. Кулакова, проф. В.Н. Прилепской, В.Е. Радзинского. М.: «ГЭОТАР-Медиа», 2006. с. 1029.Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am., 2008, 22: 637-52.Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am., 2008, 22: 637-52.Baykushev R, Ouzounova-Raykova V, Stoykova V, Mitov I. Reliable microbiological diagnosis of vulvovaginal candidiasis. Akush Ginekol (Sofiia), 2014, 53(4): 17-20.Baykushev R, Ouzounova-Raykova V, Stoykova V, Mitov I. Reliable microbiological diagnosis of vulvovaginal candidiasis. Akush Ginekol (Sofiia), 2014, 53(4): 17-20.Bassyouni RH, Wegdan AA, Abdelmoneim A, Said W, AboElnaga F. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus. J Microbiol Biotechnol., 2015, Oct 28, 25(10): 1734-41.Bassyouni RH, Wegdan AA, Abdelmoneim A, Said W, AboElnaga F. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus. J Microbiol Biotechnol., 2015, Oct 28, 25(10): 1734-41.Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG, 2015, May, 122(6): 785-94.Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG, 2015, May, 122(6): 785-94.Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in non-pregnant women: a longitudinal study. Obstet Gynecol., 2004, 104: 926-30.Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in non-pregnant women: a longitudinal study. Obstet Gynecol., 2004, 104: 926-30.Gongalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol., 2015, Dec, 21: 1-23.Gongalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol., 2015, Dec, 21: 1-23.Aguin TJ, Sobel JD. Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep., 2015 Jun, 17(6): 462.Aguin TJ, Sobel JD. Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep., 2015 Jun, 17(6): 462.Kimberly A. Workowski et al. Sexually Transmitted Diseases Treatment Guidelines. MMWR, 2010, 59(RR12): 1-110.Kimberly A. Workowski et al. Sexually Transmitted Diseases Treatment Guidelines. MMWR, 2010, 59(RR12): 1-110.Sherrard J, Donders G, White D. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. International Journal of STD & AIDS, 2011, 22: 421-429.Sherrard J, Donders G, White D. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. International Journal of STD & AIDS, 2011, 22: 421-429.Glockner A, Cornely OA. Candida glabrata-unique features and challenges in the clinical management of invasive infections. Mycoses., 2015, Aug, 58(8): 445-50.Glockner A, Cornely OA. Candida glabrata-unique features and challenges in the clinical management of invasive infections. Mycoses., 2015, Aug, 58(8): 445-50.Li H, Zhang C, Chen Z, Shi W, Sun S. A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC) - combining tacrolimus with FLC. FEMS Yeast Res., 2014, Aug, 14(5): 808-11.Li H, Zhang C, Chen Z, Shi W, Sun S. A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC) - combining tacrolimus with FLC. FEMS Yeast Res., 2014, Aug, 14(5): 808-11.Fan S, Liu X, Wu C, Xu L, Li J. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia, 2015, Feb, 179(1-2): 95-101.Fan S, Liu X, Wu C, Xu L, Li J. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia, 2015, Feb, 179(1-2): 95-101.White DJ, Habib AR, Vanthuyne A, Langford S, Symonds M. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections. Sex Transm Infect., 2001 Jun, 77(3): 212-3.White DJ, Habib AR, Vanthuyne A, Langford S, Symonds M. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections. Sex Transm Infect., 2001 Jun, 77(3): 212-3.Szweda P, Gucwa K, Romanowska E, Dzierzanowska-Fangrat K, Naumiuk L, Brillowska-Dabrowska A, Wojciechowska-Koszko I, Milewski S. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland. J Med Microbiol., 2015. Jun, 64(6): 610-9.Szweda P, Gucwa K, Romanowska E, Dzierzanowska-Fangrat K, Naumiuk L, Brillowska-Dabrowska A, Wojciechowska-Koszko I, Milewski S. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland. J Med Microbiol., 2015. Jun, 64(6): 610-9.Deorukhkar SC, Saini S. Echinocandin susceptibility profile of fluconazole resistant Candida species isolated from blood stream infections. Infect Disord Drug Targets, 2015, Dec 9.Deorukhkar SC, Saini S. Echinocandin susceptibility profile of fluconazole resistant Candida species isolated from blood stream infections. Infect Disord Drug Targets, 2015, Dec 9.Shekari Ebrahim Abad H, Zaini F, Kordbacheh P, Mahmoudi M, Safara M, Mortezaee V. In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran. Jundishapur J Microbiol., 2015, Jun 27, 8(6).Shekari Ebrahim Abad H, Zaini F, Kordbacheh P, Mahmoudi M, Safara M, Mortezaee V. In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran. Jundishapur J Microbiol., 2015, Jun 27, 8(6).Guidelines for outpatient care in obstetrics and gynecology ed. by V.I. Kulakov, prof. V.N. Prilepskaya, V.E. Radzinsky "GEOTAR-Media", 2006. p. 1029.Guidelines for outpatient care in obstetrics and gynecology ed. by V.I. Kulakov, prof. V.N. Prilepskaya, V.E. Radzinsky "GEOTAR-Media", 2006. p. 1029.

The authors declare that there are no conflicts of interest present.